PANBELA THERAPEUTICS INC (PBLA) Stock Income Statement
NASDAQ:PBLA - Nasdaq - US69833W4042 - Common Stock - Currency: USD
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 23.79M | 34.09M | 10.01M | 5.75M | 4.32M | |||
| Research and Development | 18.00M | 28.05M | 5.42M | 2.51M | 2.35M | |||
| Selling, General, and Administrative Expenses | 5.80M | 6.04M | 4.59M | 3.25M | 1.97M | |||
| Operating Income | -23.79M | -34.09M | -10.01M | -5.75M | -4.32M | |||
| Interest Income/Expense | -310.00K | -270.00K | -10.00K | -20.00K | -2.19M | |||
| Other Income/Expense | -10.00K | -680.00K | -600.00K | 610.00K | -100.00K | |||
| Non Recurring Items | N/A | N/A | 0.00 | 100.00K | N/A | |||
| Income Before Taxes | -23.71M | -35.05M | -10.62M | -5.06M | -6.62M | |||
| Income Tax | -180.00K | -120.00K | -490.00K | -300.00K | -420.00K | |||
| Net Income | -23.53M | -34.93M | -10.14M | -4.77M | -6.20M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -170.68 | -1.75K | -1.01K | -476.99 | -1.31K | |||
| Non GAAP EPS | -4.01K | -5.80K | -25.83 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD